reference/12602596

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12602596

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	2829
issn	1529-0131 0004-3591
issueIdentifier	9
pageRange	2817-2829
publicationName	Arthritis and rheumatism
startingPage	2817
bibliographicCitation	Maini RN, Taylor PC, Szechinski J, Pavelka K, Bröll J, Balint G, Emery P, Raemen F, Petersen J, Smolen J, Thomson D, Kishimoto T; CHARISMA Study Group. Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum. 2006 Sep;54(9):2817–29. doi: 10.1002/art.22033. PMID: 16947782.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a71bf8afb39f27da75b6fca264a0870 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f3126d2453ef56b3e42af2dea3702eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6185b67dcac5a4e55201cc979582344c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77238f5b8ec65f528d06a7286f69f5bf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8361f1d7df49672c327bc41899da9d24 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bdc0c65adbf1cbedfcfe5b9f73ca5684 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_47f497907a00a2990ce565226d903d30 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12029cc8de2a065cc76ce7f725b2c9cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36e55604df469d81e4368b9e1b57942b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa7cbedc8cdac2b68b557d76abdc1055 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8952c52645ad3251d6c6d4eb569aff79 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e81d85793e4f9e54995f86471bac605f
date	2006-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1002/art.22033 https://pubmed.ncbi.nlm.nih.gov/16947782
isPartOf	https://portal.issn.org/resource/ISSN/1529-0131 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/881 https://portal.issn.org/resource/ISSN/0004-3591
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Double‐blind randomized controlled clinical trial of the interleukin‐6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate
discusses	http://id.nlm.nih.gov/mesh/M0488127 http://id.nlm.nih.gov/mesh/M0029619 http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0027742 http://id.nlm.nih.gov/mesh/M0013595 http://id.nlm.nih.gov/mesh/M0001357
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D019947Q000037 http://id.nlm.nih.gov/mesh/D000911Q000627 http://id.nlm.nih.gov/mesh/D018501Q000627 http://id.nlm.nih.gov/mesh/D008727Q000627 http://id.nlm.nih.gov/mesh/D001172Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D061067 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D005060 http://id.nlm.nih.gov/mesh/D018579 http://id.nlm.nih.gov/mesh/D012449 http://id.nlm.nih.gov/mesh/D001172Q000503 http://id.nlm.nih.gov/mesh/D010146Q000453 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D017211 http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aeebd1980c6662678028fc899ba441eb http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_db534dfb811794dcf8169959477d8ea5 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460048 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.6.1.1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a7939d043567ee90a9f1febb314e563d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10308 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129046631 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127638306 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID178103463 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128121087

Total number of triples: 68.